HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Centre Asset Management LLC

Centre Asset Management LLC grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,555 shares of the company’s stock after acquiring an additional 274 shares during the quarter. Centre Asset Management LLC’s holdings in HCA Healthcare were worth $1,367,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Commonwealth Equity Services LLC increased its holdings in HCA Healthcare by 9.7% in the 2nd quarter. Commonwealth Equity Services LLC now owns 22,601 shares of the company’s stock valued at $7,262,000 after purchasing an additional 1,992 shares in the last quarter. Farther Finance Advisors LLC grew its position in HCA Healthcare by 46.0% in the second quarter. Farther Finance Advisors LLC now owns 902 shares of the company’s stock valued at $284,000 after acquiring an additional 284 shares in the last quarter. Versor Investments LP acquired a new stake in HCA Healthcare during the 2nd quarter valued at $416,000. Simon Quick Advisors LLC grew its stake in shares of HCA Healthcare by 8.4% during the second quarter. Simon Quick Advisors LLC now owns 672 shares of the company’s stock valued at $216,000 after acquiring an additional 52 shares in the last quarter. Finally, TD Asset Management Inc grew its stake in HCA Healthcare by 2.7% during the 2nd quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock valued at $238,110,000 after purchasing an additional 19,812 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on HCA. Morgan Stanley dropped their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. TD Cowen dropped their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $385.63.

HCA Healthcare Price Performance

NYSE:HCA traded down $4.06 during mid-day trading on Friday, reaching $293.69. 298,426 shares of the stock were exchanged, compared to its average volume of 596,824. The business has a fifty day moving average price of $328.27 and a 200 day moving average price of $355.06. The firm has a market capitalization of $74.39 billion, a PE ratio of 13.19, a PEG ratio of 1.21 and a beta of 1.63. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 1-year low of $271.13 and a 1-year high of $417.14.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Friday, December 13th were paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.90%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s dividend payout ratio is presently 11.85%.

Insider Activity

In related news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.